Literature DB >> 33940336

Trends and correlates of cocaine use among adults in the United States, 2006-2019.

Desiree Mustaquim1, Christopher M Jones2, Wilson M Compton3.   

Abstract

BACKGROUND: Cocaine is the most commonly reported illicit stimulant used in the U.S., yet limited research has examined recent changes in cocaine use patterns and co-occurring substance use and mental health characteristics among adults using cocaine.
METHODS: Self-report data from adults (age 18 years or older) participating in the 2006 to 2019 National Surveys on Drug Use and Health (NSDUH) were used to estimate trends in prevalence of past-year cocaine use by demographic characteristics, cocaine use disorder, cocaine injection, frequency of use. For 2018-2019, prevalence of co-occurring past-year use of other illicit and prescription substances and mental health characteristics were estimated. Multivariable logistic regression examined demographic, substance use, and mental health characteristics associated with past-year cocaine use in 2018-2019.
RESULTS: The annual average estimated prevalence of past-year cocaine use among adults was highest in 2006-2007 (2.51%), declined to 1.72% in 2010-2011, and then increased to 2.14% in 2018-2019. The annual average estimated prevalence of past-year cocaine use disorder was highest in 2006-2007 (0.71%) and declined to 0.37% in 2018-2019. Characteristics associated with higher adjusted odds of past-year cocaine use included: males; ages 18-49; Hispanic ethnicity; income <$20,000; large or small metro counties; use of other substances (nicotine, alcohol, marijuana, sedative/tranquilizers, prescription opioids, prescription stimulants, heroin, and methamphetamine); and serious psychological distress and suicidal ideation or attempt.
CONCLUSION: Additional efforts to support prevention and response capacity in communities, expand linkages to care and retention for substance use and mental health, and enhance collaborations between public health and public safety are needed. Published by Elsevier Ltd.

Entities:  

Keywords:  Alcohol; Illicit drug; Mental health; Recovery; Substance Use; Substance use treatment

Mesh:

Substances:

Year:  2021        PMID: 33940336     DOI: 10.1016/j.addbeh.2021.106950

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  6 in total

1.  Socioeconomic inequalities and Black/White disparities in US cocaine-involved overdose mortality risk.

Authors:  Manuel Cano; Christopher P Salas-Wright; Sehun Oh; Lailea Noel; Dora Hernandez; Michael G Vaughn
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-03-06       Impact factor: 4.519

2.  Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.

Authors:  Tarlise Townsend; David Kline; Ariadne Rivera-Aguirre; Amanda M Bunting; Pia M Mauro; Brandon D L Marshall; Silvia S Martins; Magdalena Cerdá
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

3.  Risky Sexual Practices, Sexually Transmitted Infections, Motivations, and Mental Health among Heterosexual Women and Men Who Practice Sexualized Drug Use in Spain.

Authors:  Daniel Íncera-Fernández; Francisco J Román; Manuel Gámez-Guadix
Journal:  Int J Environ Res Public Health       Date:  2022-05-24       Impact factor: 4.614

4.  Non-fatal stimulant overdose among homeless and unstably housed women in San Francisco, California.

Authors:  Thibaut Davy-Mendez; Eric Vittinghoff; Samantha E Dilworth; Leslie W Suen; Carl Braun; Phillip O Coffin; Derek D Satre; Elise D Riley
Journal:  Drug Alcohol Depend       Date:  2021-09-22       Impact factor: 4.492

5.  Trends of Cocaine Use and Manifestations in Hospitalized Patients: A Cross-Sectional Study.

Authors:  Karthik Gangu; Aniesh Bobba; Sanket D Basida; Sindhu Avula; Harleen Chela; Simranjit Singh
Journal:  Cureus       Date:  2022-02-10

6.  Levamisole-Adulterated Cocaine-Induced Thrombotic Vasculopathy With Negative Serology.

Authors:  Shawn Y Sunu; Kartik Dhaduk
Journal:  Cureus       Date:  2022-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.